Aglaia Oncology Funds

Aglaia Oncology Funds, established in 2003, is a private equity firm based in Bilthoven, the Netherlands. It specializes in early-stage investments in biomedical and biotechnology companies focused on oncology and cancer therapies. The firm typically invests up to EUR8 million per company, taking an active role in their strategic and operational processes. Aglaia's portfolio includes tools, technologies, and components of contemporary drug development, with a focus on preventing and curing cancer.